KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Shares Outstanding (Weighted Average) (2016 - 2025)

Evolent Health has reported Shares Outstanding (Weighted Average) over the past 12 years, most recently at $114.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $114.2 million for Q4 2025, changed 0.41% from a year ago — trailing twelve months through Dec 2025 was $114.2 million (changed 0.41% YoY), and the annual figure for FY2025 was $114.2 million, changed 0.41%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $114.2 million at Evolent Health, roughly flat from $114.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for EVH hit a ceiling of $115.6 million in Q2 2025 and a floor of $84.7 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $110.0 million (2023), compared with a mean of $103.2 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 21.62% in 2023 and later decreased 0.69% in 2025.
  • Evolent Health's Shares Outstanding (Weighted Average) stood at $86.1 million in 2021, then increased by 8.87% to $93.7 million in 2022, then increased by 18.73% to $111.3 million in 2023, then rose by 3.08% to $114.7 million in 2024, then fell by 0.41% to $114.2 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $114.2 million (Q4 2025), $114.1 million (Q3 2025), and $115.6 million (Q2 2025) per Business Quant data.